Intesa Sanpaolo's Atlante buys 10% stake in Biovelocita

Following the investment, Atlante secured a 10% stake in Biovelocita. The Milan-based accelerator was founded in November 2015 with capital provided by French venture capital house Sofinnova Partners and has a €6m target.

Atlante Seed is the early-stage-focused fund of Imi Fondi Chiusi, the asset management firm backed by Intesa Sanpaolo. The fund has raised a €10m capital commitment to date and targets Italian seed and early-stage investments in the biopharma, biotech, energy, lifestyle and communications sectors. According to a statement, the fund will invest 25% of its capital outside Italy.

Company
Biovelocita focuses on Italian early-stage investments in the biotechnology sector.

People
Intesa Sanpaolo – Davide Turco (partner).
Biovelocita – Silvano Spinelli (co-founder, chair); Gabriella Camboni (co-founder, CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• Southern Europe
• Italy
• Intesa Sanpaolo